Translate Bio

The promise of mRNA therapeutics has been held back by a fundamental physical limitation: lipid nanoparticles containing mRNA are inherently fragile and prone to aggregation when subjected to the mech

The number of biotechs that are looking for partnerships while struggling for cash suggests there are plenty of reasonably priced candidates around but there are very few high-quality late-stage asset

Management consultants use gap analyses when helping biopharmaceutical companies target their therapeutic franchises’ opportunities relative to the unmet medical need and the competition. Sanofi’s vac

The number of biotechs that are looking for partnerships while struggling for cash suggests there are plenty of reasonably priced candidates around but there are very few high-quality late-stage asset